Disease Prevention and Control, San Francisco Department of Public Health

Publications, Data, and Reports

Health Alerts, Advisories, and Updates

Communicable Disease (CD) Quarterly Reports

Communicable Disease (CD) Case Counts & Rates

  • Case Counts & Rates of Reportable Communicable Diseases in San Francisco by Year, 2013-2017 [PDF]

Reports

  • Hepatitis C Infection Surveillance Report, 2018-2019, San Francisco, July 2021 [PDF]
  • Summary Slides of the Hepatitis C Infection Surveillance Report, 2018-2019, San Francisco, July 2021 [PDF]
  • Annual Report of Communicable Diseases in San Francisco 2017, August 2019 [PDF]
  • Annual Report of Communicable Diseases in San Francisco 2016, March 2018 [PDF]
  • Annual Report of Communicable Diseases in San Francisco 2015, January 2018 [PDF]
  • Annual Report of Communicable Diseases in San Francisco 2014, September 2017 [PDF]
  • Annual Report of Communicable Diseases in San Francisco 2013, January 2017 [PDF]
  • Kindergarten Retrospective Immunization Survey 2015, July 2016 [PDF]
  • Annual Report of Communicable Diseases in San Francisco 2012, March 2015 [PDF]
  • Annual Report of Communicable Diseases in San Francisco 2011, March 2015 [PDF]
  • Kindergarten Retrospective Immunization Survey 2011, May 2012 [PDF]
  • Annual Report of Communicable Diseases in San Francisco 2010, May 2012 [PDF]
  • Chronic Hepatitis B and Hepatitis C Infection Surveillance Report 2010, San Francisco, February 2012 [PDF]
  • Annual Report of Communicable Diseases in San Francisco 2009, January 2011 [PDF]
  • Registry Match: Chronic Hepatitis B, Hepatitis C Infection and HIV 2010, San Francisco, California [PDF]
  • Influenza-Related Hospitalizations in San Francisco for the 2009-2010 Influenza Season, January 2011 [PDF]
  • Chronic Hepatitis B and Hepatitis C Infection Surveillance Report 2009, San Francisco, October 2010 [PDF]
  • Annual Report of Communicable Diseases in San Francisco 2008, January 2010 [PDF]
  • Evaluation of the Impact of Electronic Reporting on the Completeness of Data, May 1, 2008 – June 30, 2009, San Francisco, December 2009 [PDF]
  • Chronic Hepatitis B Surveillance Report, 2007-2008, San Francisco, September 2009 [PDF]
  • Annual Report of Communicable Diseases in San Francisco 2007, December 2008 [PDF]
  • Annual Report of Communicable Diseases in San Francisco 2006, January 2008 [PDF]
  • Annual Report of Communicable Diseases in San Francisco 2004-2005, August 2006 [PDF]
  • San Francisco Communicable Disease Report 1986-2003, May 2005 [PDF]
  • Biohazard Detection System (BDS) Alert Response Exercise Summary, Jan 2006 [PDF]
  • Building A Healthier San Francisco: 2004 Community Health Assessment [PDF]
  • Vaccination Ventures:  Explanation and Outcomes of a Mass Smallpox Vaccination Clinic Excercise, SFDPH, 2003 [PDF]

Posters

  • Avian Influenza Planning: Decision-Making Matrices for Epidemiology and Surveillance Activities, Feb 2007 [PDF]
  • The Clinician and Health Department Partnership Project, Feb 2007 [PDF]
  • Epidemiology and Disease Control Go-Kits, Feb 2007 [PDF]
  • Pandemic Flu Planning & Preparedness Activities in San Francisco, Feb 2007 [PDF]
  • San Francisco Community-Associated MRSA Pediatric Sentinel Surveillance 2005-2006 [PDF]
  • San Francisco’s Isolation & Quarantine Planning, Feb 2007 [PDF]
  • Strategies and Tools for Evaluating a Full-Scale Mass Prophylaxis Exercise: The San Francisco Experience, Feb 2007 [PDF]
  • Completeness of Active and Passive Surveillance in San Francisco [PDF]
  • Campylobacteriosis Surveillance in San Francisco, 2006 [PDF]

Bulletins

  • Community Health and Safety Bulletin, June/July 2004 [PDF]
  • Community Health and Safety Bulletin, October 2002 [PDF]

Articles

  • Foodborne/Gastrointestinal Illnesses:
    • Complaints of foodborne illness in San Francisco, California, 1998.  Samuel MC, Portnoy D, Tauxe RV, Angulo FJ, Vugia DJ. J Food Prot. 2001;64(8):1261-4.
    • Endemic cryptosporidiosis and exposure to municipal tap water in persons with acquired immunodeficiency syndrome (AIDS): a case-control study. Aragón TJ, Novotny S, Enanoria W, Vugia DJ, Khalakdina A, Katz MH. BMC Public Health. 2003;3(1):2 [HTML] | [PDF]
    • Risk of the hemolytic-uremic syndrome after antibiotic treatment of escherichia coli O157:H7 infections. Aragon T, Fernyak S, Reiter R. N Engl J Med. 2000 Oct 26;343(17):1271-2; author reply 1272-3.
    • Shigella sonnei outbreak among men who have sex with men — San Francisco, California, 2000–2001.CDC, Reported by: JD Klausner, MD, T Aragón, MD, WT Enanoria, MPH, JK Mann, MPH, VM Zapitz, MS, D Portnoy, MPH, SA Shallow, MPH, K Israel-Ballard, MS Kim, MPH, J O’Connell, DJ Vugia, MD. MMWR 2001;50(42):922-926.
  • Wound and Soft Tissue Infections:
    • Clostridial myonecrosis cluster among injection drug users: a molecular epidemiology investigation. Bangsberg DR, Rosen JI, Aragón T, Campbell A, Weir L, Perdreau-Remington F. Arch Intern Med. 2002 Mar 11;162(5):517-22.
    • Increasing prevalence of methicillin-resistant staphylococcus aureus infection in California jails.Pan E, Diep B, Carleton H, Charlebois E, Sensabaugh G, Haller B, & Perdreau-Remington F. Clinical Infectious Diseases, 2003;37:1384-1388.
    • Population dynamics of nasal strains of methicillin-resistant staphylococcus aureus–and their relation to community-associated disease activity.Pan ES, Diep BA, Charlebois ED, Auerswald C, Carleton HA, Sensabaugh GF, Perdreau-Remington F. J Infect Dis. 2005 Sep 1;192(5):811-8. Epub 2005 Aug 2.
  • Bioterrorism:
    • Anthrax in the Air? Chan C, Pan E, San Francisco Medicine June/July 2005 [PDF]
    • Logistics of smallpox control through ring vaccination: a stochastic network model. Porco TC, Holbrook K, Fernyak SE, Portnoy D, Reiter R, Aragón TJ. BMC Public Health 2004, 4:34. [HTML] | [PDF]
    • Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963-1968. Aragón TJ, Ulrich S, Fernyak S, Rutherford GW. BMC Public Health. 2003 Aug 11;3(1):26. [HTML] | [PDF]
    • The risks and benefits of pre-event smallpox vaccination: where you stand depends on where you sit. Aragón TJ, Fernyak SE. Ann Emerg Med. 2003 Nov;42(5):681 [PDF]
  • Miscellaneous:
    • Knowledge of hepatitis B risk factors and prevention practices among individuals chronically infected with hepatitis B in San Francisco, California. Nishimura A, Shiono P, Stier D, Shallow S, Sanchez M, Huang S. Journal of Community Health. 2011. DOI: 10.1007/s10900-011-9430-2. [HTML]
    • On the Frontline: San Francisco Physicians Serve as Primary Sources for Disease Detectives. Huang S, San Francisco Medicine March 2007 [PDF]
    • Public Health Update: Preparing for Pandemic Influenza. Bruch O, Holbrook K, San Francisco Medicine July 2006 [PDF]
    • Outbreaks of of noscomial group A streptococcal infections associated with asymptomatic health care workers – Maryland and California, 1997. CDC, Reported by Aragón T, Katz M, Mintz L, Waterman S, Lacey T, Bradshaw D, Sanders M, Dwyer D. Morbidity and Mortality Weekly Report 1999;48(8):163-166
    • Risk of infection from needle reuse at a phlebotomy center. Porco TC, Aragon TJ, Fernyak SE, Cody SH, Vugia DJ, Katz MH, Bangsberg DR. Am J Public Health. 2001;91(4):636-8.
    • Use of preventive services by managed care enrollees: an updated perspective. Phillips KA, Fernyak S, Potosky AL, Schauffler HH, Egorin M. Health Aff (Millwood). 2000 Jan-Feb;19(1):102-16.
    • Viral infections of the fetus and newborn. Pan E, Cole FS, & Weintrub P. In Taeusch HW, Ballard RA, Gleason CA. (eds.): Avery’s Diseases of the Newborn, 8th edition. Philadelphia, Harcourt Health Sciences, 2005.
Tuberculosis Control Reports and Publications